UK to offer COVID-19 vaccines for young children with medical conditions
Reuters
Published Apr 06, 2023 12:58
Updated Apr 06, 2023 21:10
(Reuters) -Children aged between six months to four years with underlying medical conditions will be offered COVID-19 shots, Britain's vaccine advisers said on Thursday.
The Joint Committee on Vaccination and Immunisation (JCVI) said eligible children should be offered two doses of the vaccine, with an interval of eight to 12 weeks between the first and second doses.
Britain's health regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), had authorised the vaccine - made by Pfizer (NYSE:PFE) and BioNTech - for the same age group in December.
U.S. officials rolled out the Pfizer-BioNTech shot for the age group last year.
Data from the U.S. showed most common side effects reported were similar to those seen with other vaccines given in this age group, such as irritability or crying, sleepiness, and fever, the JCVI statement said.
The JCVI, however, said it does not advise vaccination of children between six months to four years who are not in a clinical risk group.
NHS England confirmed it would begin offering vaccinations to those eligible from mid-June.
Health and Social Secretary Steve Barclay said he had accepted JCVI's advise.
Get The App
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.